Primary study · included by 1 review

Botulinum toxin type A for drooling in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study

Lagalla 2006 · Lagalla Giovanni, Millevolte Marzia, Capecci Marianna, et al. · Movement Disorders · 2006

doi:10.1002/mds.20793journal-article

Trial PICO

Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.

Results

Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.

Included by

The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis.

Non-Cochrane · intervention · 2023 · cited as Lagalla 2006 · Table 1; Ref [43] (Mov Disord 2006); DSFS (Fig. 4, BoNt-A) and adverse events (Fig. 6, BoNt-A)

The review does not say which of its outcomes this study informs.

1 including review in total.